Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
Pharmalot
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Business
STAT+

Investors are pouring more money into biotech funds, and stocks are responding

  • Adam Feuerstein

By Adam Feuerstein Aug. 3, 2018

Reprints

Biotech fund flows are almost back to even.

Investors deposited another $417 million into health care and biotech funds this week — helping to nearly erase the net outflows from the sector this year and contributing to the strong performance of biotech stocks overall.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

Their tissue turns to bone. Their joints freeze in…
Their tissue turns to bone. Their joints freeze in place. And, finally, their hopes for treatment…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Experts debate: Are we playing with fire when we…
Experts debate: Are we playing with fire when we edit human genes?
Biden administration goes easy on Medicare Advantage insurers after…
Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying
European Union drug pricing proposal for the pandemic treaty…
European Union drug pricing proposal for the pandemic treaty generates pushback
Inflation caused a sizable drop in net drug prices…
Inflation caused a sizable drop in net drug prices in late 2022, analysis finds

Comments are closed.

Recommended Stories